Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat

Marleen H M Hessel1, Paul Steendijk, Brigit den Adel

  • 1Dept. of Cardiology, C5-P, Leiden Univ. Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands.

Insights

Monocrotaline (MCT) induced dose-dependent right ventricular (RV) hypertrophy and remodeling in rats. Even without failure, RV volumes increased, showing significant changes in RV function under pressure overload.

Area of Science:

  • Cardiovascular Physiology
  • Pulmonary Hypertension Research
  • Animal Models in Cardiology

Background:

  • Pulmonary hypertension (PH) leads to right ventricular (RV) dysfunction and failure.
  • Understanding RV structural and functional changes in response to pressure overload is crucial for developing effective treatments.
  • The monocrotaline (MCT) rat model is widely used to study PH and its effects on the RV.

Purpose of the Study:

  • To characterize hemodynamics and RV function in relation to structural changes in a rat model of MCT-induced pulmonary hypertension.
  • To investigate the dose-dependent effects of MCT on RV hypertrophy, remodeling, and function.
  • To assess RV systolic and diastolic function and stiffness in compensated and failing RV states.

Main Methods:

  • Rats were treated with varying doses of monocrotaline (MCT) to induce pulmonary hypertension.
  • Hemodynamic parameters and RV pressure-volume relations were assessed using a pressure-conductance catheter.
  • RV, left ventricle (LV), and interventricular septum (IVS) weights were measured, and histochemical analysis was performed.

Main Results:

  • MCT treatment resulted in a dose-dependent increase in RV hypertrophy, confirmed by increased RV/(LV + IVS) weight ratio.
  • RV ejection fraction was significantly reduced in MCT-treated rats, indicating impaired systolic function.
  • MCT30 rats showed maintained cardiac output but increased RV volumes and filling pressures (remodeling), while MCT80 rats exhibited decreased cardiac output and increased RV pressures and volumes.

Conclusions:

  • MCT-induced pressure overload causes dose-dependent RV hypertrophy and remodeling.
  • Increased RV end-systolic and end-diastolic volumes occur even in compensated RV states, highlighting early adaptive changes.
  • RV stiffness remained unchanged, suggesting interstitial fibrosis was not a primary factor in this model.

Related Concept Videos